New revision of Team-NB Best Practice Guidance released
New revision of Team-NB Best Practice Guidance released
Regulatory Affairs Medical Devices
Wednesday, 23 April 2025
Kirsten Van Garsse, Authorized Representative Director & Regulatory Affairs Manager IVD
Share
\
\
X (Twitter) 
\
\
LinkedIn 
\
\
WhatsApp 
\
\
Copy link 
\
\
Mail
On April 14th, 2025, Team-NB, the European Association of Medical Devices Notified Bodies, released a revision of their Best Practice Guidance for the submission of Technical Documentation under Regulation (EU) 2017/745 (MDR
Play
New revision of Team-NB Best Practice Guidance Released | QbD Group
AI-generated audio
2:02
This third revision contains several content updates, examples of common manufacturer’s pitfalls, and a significant rewrite of sections on clinical evaluation and post-market surveillance.
What is new?
Version 3 of this Team-NB Best Practice Guidance was developed after reviewing over 20 best practice guidance documents from individual notified bodies, with the purpose to develop a unified approach on the expectations of technical documentation submissions from manufacturers of medical devices.
The guidance lists detailed requirements and expectations for each of the MDR Annex II (Technical Documentation) and Annex III (Technical Documentation on Post-Market Surveillance) sections and subsections. In addition, common pitfalls as observed by notified bodies are provided throughout the entire document. The revised guidance now counts almost 80 pages, of which more than 20 pages are dedicated to clinical evaluation guidance and pitfalls. Finally, more detailed guidance is now provided on the elements to be integrated in a Post-Market Surveillance Plan and a Periodic Safety Update Report for a medical device under MDR.
What does it mean to you?
This Team-NB MDR Technical Documentation Best Practice Guidance is important for all medical device manufacturers. While every notified body may still have some specific requirements and/or expectations, this document provides manufacturers with valuable information on notified bodies’ common expectations for medical device technical documentation, when being submitted by manufacturers.
Discover more expert content
Previous
Regulatory Affairs
17 Dec 2025
Proposal for a Regulation Amending MDR and IVDR
The proposal introduces wide-ranging changes across the device lifecycle. It focuses on ...
Regulatory Affairs
11 Jul 2024
Publication of Amendments to Regulation (EU) 2024/1860
Regulation (EU) 2024/1860 as regards a gradual roll-out of Eudamed, the obligation to inform in...
Regulatory Affairs
17 Nov 2025
Team-NB publishes two new Position Papers
On October 22nd Team-NB published two new Position Papers. One addresses changes to companion...
Regulatory Affairs
23 Apr 2025
New revision of Team-NB Position Paper on European AI Act
This Position Paper provides an overview of the Team-NB perspective on the challenges of the AI...
Regulatory Affairs
23 Apr 2025
New Team-NB Position Paper Released on IVDR certification process
This Position Paper is a Team-NB consensus document describing the pre-application, application and...
Regulatory Affairs
17 Dec 2025
Proposal for a Regulation Amending MDR and IVDR
The proposal introduces wide-ranging changes across the device lifecycle. It focuses on ...
Regulatory Affairs
11 Jul 2024
Publication of Amendments to Regulation (EU) 2024/1860
Regulation (EU) 2024/1860 as regards a gradual roll-out of Eudamed, the obligation to inform in...
Regulatory Affairs
17 Nov 2025
Team-NB publishes two new Position Papers
On October 22nd Team-NB published two new Position Papers. One addresses changes to companion...
Regulatory Affairs
23 Apr 2025
New revision of Team-NB Position Paper on European AI Act
This Position Paper provides an overview of the Team-NB perspective on the challenges of the AI...
Regulatory Affairs
23 Apr 2025
New Team-NB Position Paper Released on IVDR certification process
This Position Paper is a Team-NB consensus document describing the pre-application, application and...
Regulatory Affairs
17 Dec 2025
Proposal for a Regulation Amending MDR and IVDR
The proposal introduces wide-ranging changes across the device lifecycle. It focuses on ...
Regulatory Affairs
11 Jul 2024
Publication of Amendments to Regulation (EU) 2024/1860
Regulation (EU) 2024/1860 as regards a gradual roll-out of Eudamed, the obligation to inform in...
Next
- 1
- 2
- 3
Stay ahead in life sciences
Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.
Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.
Twitter Widget Iframe